** Shares of Alcidion Group Ltd ALC.AX rise as much as 20.8% to A$0.145, their highest level since February 24, 2023
** The healthcare technology firm generates FY25 new total contract value $(TCV)$ sales of A$73.8 million ($48.82 million), up 10.9% from a year earlier
** Reconfirms outlook of FY25 EBITDA exceeding A$4.5 mln
** Co will release FY25 earnings results and FY26 guidance on August 28
** Around 5.7 mln shares change hands, 4.4x the 30-day avg
** Stock last up 4.2%, bringing YTD gains to 108.3%
($1 = 1.5117 Australian dollars)
(Reporting by Shruti Agarwal in Bengaluru)
((Shruti.Agarwal@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。